5/31/24 16:05 | 5/29/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -261 | 21.73 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
5/31/24 16:05 | 5/29/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
5/1/24 19:04 | 4/29/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -215 | 17.92 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
5/1/24 19:04 | 4/29/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
4/15/24 19:06 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -751 | 25.04 | 0 | -30 | -3 | 1,117 | D | | | | | | | | | | | | | | |
4/15/24 19:06 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 34 | 1.12 | 0 | 30 | 3 | 1,117 | D | | | | | | | | | | | | | | |
4/3/24 21:30 | 4/1/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -223 | 18.60 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
4/3/24 21:30 | 4/1/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
3/4/24 17:55 | 2/29/24 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -197 | 16.42 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
3/4/24 17:55 | 2/29/24 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
1/31/24 21:22 | 1/29/24 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -190 | 15.85 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
1/31/24 21:22 | 1/29/24 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
1/3/24 19:01 | 12/29/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -171 | 14.28 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |
1/3/24 19:01 | 12/29/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
12/26/23 19:32 | 12/21/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.dm | -86 | 13.07 | 0 | -7 | -1 | 1,117 | D | | | | | | | | | | | | | | |
12/26/23 19:32 | 12/21/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.dm | 7 | 1.12 | 0 | 7 | 1 | 1,117 | D | | | | | | | | | | | | | | |
12/21/23 16:29 | 12/19/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.dm | -116 | 13.01 | 0 | -9 | -1 | 1,117 | D | | | | | | | | | | | | | | |
12/21/23 16:29 | 12/19/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.dm | 10 | 1.12 | 0 | 9 | 1 | 1,117 | D | | | | | | | | | | | | | | |
11/6/23 16:43 | 11/3/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -112 | 13.08 | 0 | -9 | -1 | 1,117 | D | | | | | | | | | | | | | | |
11/6/23 16:43 | 11/3/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 10 | 1.12 | 0 | 9 | 1 | 1,117 | D | | | | | | | | | | | | | | |
10/3/23 19:40 | 9/29/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | M.d | 13 | 1.12 | 0 | 12 | 1 | 1,117 | D | | | | | | | | | | | | | | |
10/3/23 19:40 | 9/29/23 | ELVN | Enliven Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | DO | Chief Sc | S.d | -163 | 13.62 | 0 | -12 | -1 | 1,117 | D | | | | | | | | | | | | | | |